Gene · 6624
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell analysis of lung cancer metabolism and its clinical implications. | Cancer Treat Res Commun | 2026 | 41352205 | PubTator, text mining | PubMed |
| Characterization and Prognostic Impact of Fascin Expression in the Tumor Microenvironment of Triple-Negative Breast Cancer: Clues for a Tailored Therapy. | Lab Invest | 2026 | 41319754 | PubTator, text mining | PubMed |
| EXPRESSION OF CONCERN: Long Non-coding RNA Urothelial Cancer-associated 1 Promotes Bladder Cancer Cell Migration and Invasion by Way of the hsa-miR-145-ZEB1/2-FSCN1 Pathway. | Cancer Sci | 2026 | 41163296 | PubTator, text mining | PubMed |
| FSCN1 as a Candidate Gene for Syndromic Intellectual Disability? Evidence From a Recurrent Variant in an Iranian Cohort. | Clin Genet | 2026 | 40874942 | PubTator, text mining | PubMed |
| Diagnostic value and clinical significance of Ki-67, PI3K, and Fascin in patients with oral squamous cell carcinoma. | J Med Biochem | 2025 | 41799177 | PubTator, text mining | PubMed |
| Research progress of glutarimide-containing polyketides: Structures, bioactivities and their biosynthesis. | Pharm Sci Adv | 2025 | 41550660 | PubTator, text mining | PubMed |
| Fascin Drives Breast Cancer Cell Proliferation Partly by Modulating the Cell Cycle Checkpoint Regulators of the G1-S Phase. | Cells | 2025 | 41369328 | PubTator, text mining | PubMed |
| Statistical methods to disentangle genetic effects influencing infertility and early fetal viability with a genome-wide application. | PLoS Genet | 2025 | 41325449 | PubTator, text mining | PubMed |
| High Expression of Actin Binding Proteins Predicts Hematogenous Metastases in Non-Small Cell Lung Cancer. | Asian Pac J Cancer Prev | 2025 | 41312930 | PubTator, text mining | PubMed |
| Cytoskeletal Remodeling by Oncoviruses: A Key Factor in Tumor Invasion and Metastasisa. | Cell Biochem Funct | 2025 | 41299867 | PubTator, text mining | PubMed |
| FRA1 drives melanoma metastasis through an actionable transcriptional network. | Oncogene | 2025 | 41286309 | PubTator, text mining | PubMed |
| BioEmu: AI-Powered Revolution in Scalable Protein Dynamics Simulation. | J Cell Mol Med | 2025 | 41284381 | PubTator, text mining | PubMed |
| Localization of Fascin to Dendritic Protrusions Regulates Postsynaptic Plasticity. | bioRxiv | 2025 | 41256569 | PubTator, text mining | PubMed |
| Combining Nanoscale Curvature and Polymer Osmotic Pressure for Efficient Giant Vesicle Assembly Under Physiological Conditions. | Small Methods | 2025 | 41229203 | PubTator, text mining | PubMed |
| The Cytoskeleton in Adrenal Physiology and Tumours: Functional Roles and Emerging Molecular Targets. | Int J Mol Sci | 2025 | 41226387 | PubTator, text mining | PubMed |
| Triclabendazole inhibits PKM2 nuclear localization and glycolysis by enhancing HDAC6-mediated deacetylation in lung cancer. | J Transl Med | 2025 | 40993625 | PubTator, text mining | PubMed |
| Alpha synuclein-mediated cytoskeletal dysfunction impairs myelination in human oligodendrocytes. | Acta Neuropathol | 2025 | 40973885 | PubTator, text mining | PubMed |
| Structure of the Huntingtin F-actin complex reveals its role in cytoskeleton organization. | Sci Adv | 2025 | 40971423 | PubTator, text mining | PubMed |
| Impaired migration and lung invasion of human melanoma by a novel small molecule targeting the transmembrane domain of death receptor p75NTR. | EMBO Mol Med | 2025 | 40962940 | PubTator, text mining | PubMed |
| Spatial Single-Cell Atlas Reveals KSHV-Driven Broad Cellular Reprogramming, Progenitor Expansion, Immune and Vascular Remodeling in Kaposi's Sarcoma. | bioRxiv | 2025 | 40949967 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6624/papers?page=3